top of page

Hereditary Cancer Screening

Phronetik offers a comprehensive Women's Health Hereditary Cancer Screening program, leveraging state-of-the-art Next-Generation Sequencing (NGS) technology to identify genetic mutations associated with a higher risk of developing cancers that commonly affect women. This service is particularly focused on cancers such as breast, ovarian, endometrial, and colorectal cancers, among others. By pinpointing specific genetic variations, we empower women with crucial information about their cancer risk, enabling early detection strategies, personalized surveillance, and proactive management plans

Image by CDC

Why Choose Phronetik for Hereditary Cancer Screening?


Cutting-Edge Technology

Our use of NGS technology ensures high accuracy and the ability to screen for multiple genes simultaneously, providing a comprehensive overview of cancer risk.


Expertise and Support

Phronetik boasts a team of experts, including geneticists, clinicians, and genetic counselors, who provide support and guidance throughout the testing process, from sample collection to result interpretation and follow-up.


Confidential and Ethical Considerations

We uphold the highest standards of confidentiality and ethical considerations, ensuring that patients’ genetic information is securely protected and used responsibly.


Integrated Care Approach

Our service is designed to integrate seamlessly with existing healthcare plans, facilitating collaboration with healthcare providers to implement the most effective surveillance and management strategies.

More Clinical Diagnostic Services

bottom of page